| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Golgicide A | 1005036-73-6 | sc-215103 sc-215103A | 5 mg 25 mg | $191.00 $683.00 | 11 | |
Golgicide A acts as a potent inhibitor of ARF1 by specifically targeting its guanine nucleotide exchange factor (GEF) interactions. This compound disrupts the activation cycle of ARF1, leading to altered vesicular transport and Golgi apparatus integrity. Its unique structural features allow for selective binding, influencing the kinetics of ARF1-mediated membrane dynamics. By modulating these interactions, Golgicide A plays a critical role in cellular organization and trafficking pathways. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Disrupts the function of the guanine nucleotide exchange factor (GEF) for ARF1, inhibiting ARF1 activation. This leads to the prevention of vesicle formation and trafficking, impacting cellular processes dependent on ARF1-mediated vesicular transport. | ||||||
SecinH3 | 853625-60-2 | sc-203260 | 5 mg | $278.00 | 6 | |
Blocks the activity of the ARF guanine nucleotide exchange factor (ARF GEF), inhibiting ARF1 activation. This inhibition disrupts the normal functioning of ARF1 in vesicle formation and trafficking, impacting cellular processes reliant on ARF1-mediated intracellular transport. | ||||||
Exo2 | 304684-77-3 | sc-215011 sc-215011A | 5 mg 25 mg | $89.00 $288.00 | 1 | |
Inhibits ARF1 activation by targeting the ARF guanine nucleotide exchange factor (ARF GEF). By disrupting the ARF1-GTP cycle, Exo2 interferes with vesicle formation and trafficking, influencing cellular processes dependent on ARF1-mediated intracellular transport. | ||||||
Wnt Synergist, QS11 | 944328-88-5 | sc-222417 sc-222417A | 5 mg 25 mg | $141.00 $607.00 | ||
Inhibits ARF1 activation by disrupting the function of the ARF guanine nucleotide exchange factor (ARF GEF). This interference with the ARF1-GTP cycle impacts vesicle formation and trafficking, affecting cellular processes reliant on ARF1-mediated intracellular transport. | ||||||